Please assess the completion status of the following clinical trial:

Trial Title: A Prospective, Randomized Study Evaluating the Effect of Biliary Stenting on EAU-FNA in Patients With Suspected Malignant Biliary Obstruction

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Subjects must be able to review and sign informed consent.~* Subjects must require biliary stenting for the relief of their symptoms as well as FNA biopsy for proper diagnosis.~* Suspected mass should be located in the head, uncinate, or neck of the pancreas.~Exclusion Criteria:~* Cannot give and sign informed consent.~* The suspected mass is located in the body or tail of the pancreas.~* The patient may be a candidate for palliative biliary stenting (in which a metal stent would be placed)

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- EUS-FNA First (Type: ACTIVE_COMPARATOR): Patients will undergo EUS-FNA first, followed by ERCP with biliary stenting (using a plastic stent).
- ERCP with stent placement first (Type: ACTIVE_COMPARATOR): Patients will undergo ERCP with stent placement first, followed by EUS-FNA.

Based on this trial design, predict the completion outcome and termination type (if applicable).